Share Name Share Symbol Market Type Share ISIN Share Description
Provexis Plc LSE:PXS London Ordinary Share GB00B0923P27 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.04p -4.21% 0.91p 0.85p 0.97p 0.95p 0.87p 0.90p 13,611,339.00 16:35:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 0.1 -0.5 -0.0 - 15.84

Provexis (PXS) Latest News

More Provexis News
Provexis Takeover Rumours

Provexis (PXS) Share Charts

1 Year Provexis Chart

1 Year Provexis Chart

1 Month Provexis Chart

1 Month Provexis Chart

Intraday Provexis Chart

Intraday Provexis Chart

Provexis (PXS) Discussions and Chat

Provexis Forums and Chat

Date Time Title Posts
03/12/201602:14Provexis: a new beginning879.00
27/11/201611:05PROVEXIS PLC (Sirco)40,145.00
27/4/201311:43Blatherskites, trolls, bashers & duplicitous 'investors'631.00
04/9/201216:24PXS herd mentality, medicine, moneymen and manipulation3,710.00
20/6/201200:07The Pixies 'Time To Grow Your Tomatoes' Thread54.00

Add a New Thread

Provexis (PXS) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Provexis trades in real-time

Provexis (PXS) Top Chat Posts

Provexis Daily Update: Provexis Plc is listed in the Food Producers sector of the London Stock Exchange with ticker PXS. The last closing price for Provexis was 0.95p.
Provexis Plc has a 4 week average price of 0.65p and a 12 week average price of 0.51p.
The 1 year high share price is 1.25p while the 1 year low share price is currently 0.23p.
There are currently 1,740,401,507 shares in issue and the average daily traded volume is 40,969,701 shares. The market capitalisation of Provexis Plc is £15,837,653.71.
underhill2: A lot of nonsense posts posts this weekend as expected.As a long term investment speculative investment I'm more than happy to hold. The BP results will be very important and will have a major affect on the share price either positive or negative.
underhill2: Would not surprise me if we are a takeover here within the next couple of years. The potential as a safe alternative to aspirin is enormous.I would not be suprised to see the share price at a much higher level in a years time. Under 1p will soon be a distant memory. This is all in my opinion of course. As I said yesterday it's a speculative investment but the rewards could be fantastic.
underhill2: In my portfolio this is a long term Investment. The potential Market in China is enormous. Yes the share price will be subject to large daily swings. It's a speculative investment and not without risk. Hopefully this will come good
wheelds: From the news:- Promoting Fruitflow plus omega 3:- "scientists at Provexis have extracted these ingredients and combined them with omega-3 in capsule that has been classified as a food. Experts said for at least six weeks, the supplement will work to promote normal blood flow and normal heart function." All looking good.IMHO Last time collaboration with Coca Cola the share price rose to 15p/20p before Coca Cola pulled out and share price fell to ridiculously low levels like 0.25p but now back on track with Chinese collaboration deal and latest news, and I can not see the Chinese pulling out or DSM pulling out with their Omega 3 now combined with our Fruitflow. .
wheelds: News out today on Aspirin verus Fruitflow tests:- That's on top of the China Collaboration deal; so all looking good and being reported in the press. So all good for share price rise: And you never know, last time on news of Collaboration between Coca Cola on top of good news like this, shares price rose to 15p/20p before Coca Cola pulled out and share price fell; But this time I can't see the Chinese pulling out and the medical profession ignoring the aspirin - Fruitflow results this time around. "The study findings are significant and serve to demonstrate the potential effectiveness of Fruitflow® as a dietary supplement with a significant effect on blood flow, suitable for daily use in primary prevention of CVD, and with no adverse side effects." "The World Health Organization reports that more people die annually from CVDs than from any other cause¹ and the global market for cardiovascular disease, to include dietary supplements, is estimated to be in excess of $10 billion per year." "The US FDA states that after carefully examining scientific data from major studies, it has concluded 'the data do not support the use of aspirin as a preventive medication by people who have not had a heart attack, stroke or cardiovascular problems, a use that is called 'primary prevention.' In such people, the benefit has not been established but risks - such as dangerous bleeding into the brain or stomach - are still present.' ²
wheelds: Same as last time; when good news of partnership with Coca Cola and the share price rose and fell and rose and fell and over the year rose from 0.6p to around 15p-22p before Coca Cola pulled out after the end of the year. So, in my opinion the share price will rise and fall but over the year will be much higher then today; - Last time when it got to 5p it then dropped to 3p and the rose again to 8p etc. etc. We have a great product with Fruitflow and as the good Chinese news spreads around the globe you will get other large companies in America etc. seeing this as a challenge to their health products and will try to also get a trade deal/partnership deal going with DSM and Provexis for our Fruitflow. IMHO
wheelds: "Developer of the Fruitflow heart-health functional food product, Provexis, announced on Friday that the company's alliance partner for Fruitflow, DSM Nutritional Products, has entered into a strategic collaboration agreement for Fruitflow with BY-HEALTH Co, a substantial listed Chinese dietary supplement business." And the share price rises today, all good information.IMHO
hatey: They signed that 10 years ago and look where they are now. Everybody that is promoting PXS on here and LSE are day traders.
wheelds: Today was another good day for the share price which clearly shows the market expectations for our Fruitflow + Omega 3; the enhanced revenues from our Global million dollar partner DSM; the increased revenues from our 50 plus Fruitflow products around the world as promotion via videos out and the round table of expert advertisers; and growing concern of governments around the world of costs of heart health issues; and the expected good results this year from blood pressure management trials via using our Fruitlow all adds up to improved market expectations. IMHO Hence, I bought a few more last week and yesterday and even today as I genuinely believe that our preventative Fruiflow product is a marvellous health product but it has taken time to get over the hurdles of big business interests in the established heart health drugs after you have had a heart attack etc..IMHO
wheelds: We have had a terrible last 5 years but all being well we are hopefully now on the mend which will be highlighted come this September..IMHO 07:00 02-Aug-2016 PXS Results of Placing RNS +2.44% Up 07:00 12-Jul-2016 PXS Study Publication RNS +5.39% Up 07:05 29-Jun-2016 PXS Funding Update RNS +8.61% Up 07:00 29-Jun-2016 PXS Product Launch RNS +8.61% Up July low share price 0.26p today 0.36p = 40% rise in one month. Preliminary Results September 2016 Annual General Meeting 30 September 2016
Provexis share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20161203 23:57:12